154 related articles for article (PubMed ID: 34569452)
21. Membrane depolarization induces the undulating phosphorylation/dephosphorylation of glycogen synthase kinase 3beta, and this dephosphorylation involves protein phosphatases 2A and 2B in SH-SY5Y human neuroblastoma cells.
Lee YI; Seo M; Kim Y; Kim SY; Kang UG; Kim YS; Juhnn YS
J Biol Chem; 2005 Jun; 280(23):22044-52. PubMed ID: 15799972
[TBL] [Abstract][Full Text] [Related]
22. PROTAC-Induced Glycogen Synthase Kinase 3β Degradation as a Potential Therapeutic Strategy for Alzheimer's Disease.
Guardigni M; Pruccoli L; Santini A; Simone A; Bersani M; Spyrakis F; Frabetti F; Uliassi E; Andrisano V; Pagliarani B; Fernández-Gómez P; Palomo V; Bolognesi ML; Tarozzi A; Milelli A
ACS Chem Neurosci; 2023 Jun; 14(11):1963-1970. PubMed ID: 37218653
[TBL] [Abstract][Full Text] [Related]
23. Virtual Screening and Testing of GSK-3 Inhibitors Using Human SH-SY5Y Cells Expressing Tau Folding Reporter and Mouse Hippocampal Primary Culture under Tau Cytotoxicity.
Lin CH; Hsieh YS; Sun YC; Huang WH; Chen SL; Weng ZK; Lin TH; Wu YR; Chang KH; Huang HJ; Lee GC; Hsieh-Li HM; Lee-Chen GJ
Biomol Ther (Seoul); 2023 Jan; 31(1):127-138. PubMed ID: 35790892
[TBL] [Abstract][Full Text] [Related]
24. Calcineurin dephosphorylates glycogen synthase kinase-3 beta at serine-9 in neuroblast-derived cells.
Kim Y; Lee YI; Seo M; Kim SY; Lee JE; Youn HD; Kim YS; Juhnn YS
J Neurochem; 2009 Oct; 111(2):344-54. PubMed ID: 19659461
[TBL] [Abstract][Full Text] [Related]
25. Curcumin mediates presenilin-1 activity to reduce β-amyloid production in a model of Alzheimer's Disease.
Xiong Z; Hongmei Z; Lu S; Yu L
Pharmacol Rep; 2011; 63(5):1101-8. PubMed ID: 22180352
[TBL] [Abstract][Full Text] [Related]
26. Molecular dynamics simulation studies of GSK-3β ATP competitive inhibitors: understanding the factors contributing to selectivity.
Arfeen M; Patel R; Khan T; Bharatam PV
J Biomol Struct Dyn; 2015; 33(12):2578-93. PubMed ID: 26209183
[TBL] [Abstract][Full Text] [Related]
27. Rosmarinic Acid Derivatives' Inhibition of Glycogen Synthase Kinase-3β Is the Pharmacological Basis of Kangen-Karyu in Alzheimer's Disease.
Paudel P; Seong SH; Zhou Y; Park CH; Yokozawa T; Jung HA; Choi JS
Molecules; 2018 Nov; 23(11):. PubMed ID: 30413117
[TBL] [Abstract][Full Text] [Related]
28. Identification of novel scaffold of benzothiazepinones as non-ATP competitive glycogen synthase kinase-3β inhibitors through virtual screening.
Zhang P; Hu HR; Huang ZH; Lei JY; Chu Y; Ye DY
Bioorg Med Chem Lett; 2012 Dec; 22(23):7232-6. PubMed ID: 23099099
[TBL] [Abstract][Full Text] [Related]
29. GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line.
Dickey A; Schleicher S; Leahy K; Hu R; Hallahan D; Thotala DK
J Neurooncol; 2011 Aug; 104(1):145-53. PubMed ID: 21161565
[TBL] [Abstract][Full Text] [Related]
30. Famotidine has a neuroprotective effect on MK-801 induced toxicity via the Akt/GSK-3β/β-catenin signaling pathway in the SH-SY5Y cell line.
Unal G; Dokumaci AH; Ozkartal CS; Yerer MB; Aricioglu F
Chem Biol Interact; 2019 Dec; 314():108823. PubMed ID: 31563592
[TBL] [Abstract][Full Text] [Related]
31. Molecular docking study of GSK-3β interaction with nomilin, kihadanin B, and related limonoids and triterpenes with a furyl-δ-lactone core.
Vergoten G; Bailly C
J Biochem Mol Toxicol; 2022 Sep; 36(9):e23130. PubMed ID: 35686814
[TBL] [Abstract][Full Text] [Related]
32. Discovery of novel β-carboline derivatives as selective AChE inhibitors with GSK-3β inhibitory property for the treatment of Alzheimer's disease.
Liu W; Liu X; Liu W; Gao Y; Wu L; Huang Y; Chen H; Li D; Zhou L; Wang N; Xu Z; Jiang X; Zhao Q
Eur J Med Chem; 2022 Feb; 229():114095. PubMed ID: 34995924
[TBL] [Abstract][Full Text] [Related]
33. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
[TBL] [Abstract][Full Text] [Related]
34. Tideglusib attenuates growth of neuroblastoma cancer stem/progenitor cells in vitro and in vivo by specifically targeting GSK-3β.
Bahmad HF; Chalhoub RM; Harati H; Bou-Gharios J; Assi S; Ballout F; Monzer A; Msheik H; Araji T; Elajami MK; Ghanem P; Chamaa F; Kadara H; Abou-Antoun T; Daoud G; Fares Y; Abou-Kheir W
Pharmacol Rep; 2021 Feb; 73(1):211-226. PubMed ID: 33030673
[TBL] [Abstract][Full Text] [Related]
35. Investigation of the anti-cancer potential of epoxyazadiradione in neuroblastoma: experimental assays and molecular analysis.
Chandel S; Bhattacharya A; Gautam A; Zeng W; Alka O; Sachsenberg T; Gupta GD; Narang RK; Ravichandiran V; Singh R
J Biomol Struct Dyn; 2023 Sep; ():1-19. PubMed ID: 37753734
[TBL] [Abstract][Full Text] [Related]
36. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma.
Khor TO; Gul YA; Ithnin H; Seow HF
Cancer Lett; 2004 Jul; 210(2):139-50. PubMed ID: 15183529
[TBL] [Abstract][Full Text] [Related]
37. Inactivation of integrin-linked kinase induces aberrant tau phosphorylation via sustained activation of glycogen synthase kinase 3beta in N1E-115 neuroblastoma cells.
Ishii T; Furuoka H; Muroi Y; Nishimura M
J Biol Chem; 2003 Jul; 278(29):26970-5. PubMed ID: 12714590
[TBL] [Abstract][Full Text] [Related]
38. Anti-dengue infectivity evaluation of bioflavonoid from
Dwivedi VD; Bharadwaj S; Afroz S; Khan N; Ansari MA; Yadava U; Tripathi RC; Tripathi IP; Mishra SK; Kang SG
J Biomol Struct Dyn; 2021 Mar; 39(4):1417-1430. PubMed ID: 32107969
[TBL] [Abstract][Full Text] [Related]
39. Novel benzothiazinones (BTOs) as allosteric modulator or substrate competitive inhibitor of glycogen synthase kinase 3β (GSK-3β) with cellular activity of promoting glucose uptake.
Zhang P; Li S; Gao Y; Lu W; Huang K; Ye D; Li X; Chu Y
Bioorg Med Chem Lett; 2014 Dec; 24(24):5639-5643. PubMed ID: 25467150
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of glycogen synthase kinase by curcumin: Investigation by simulated molecular docking and subsequent in vitro/in vivo evaluation.
Bustanji Y; Taha MO; Almasri IM; Al-Ghussein MA; Mohammad MK; Alkhatib HS
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):771-8. PubMed ID: 18720192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
